Intake of nanoparticles and impact on gut microbiota: in vitro and animal models available for testing
Gut Microbiome · 2022 · 3
DOI: 10.1017/gmb.2021.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gut Microbiome, online erschienen am 28.12.2021. Verfasst von Débora Campos und 3 weiteren Autor:innen. Beteiligte Einrichtung: CBQF-Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Porto, Portug…. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia.
Abstract (Originalsprache)
The oral delivery of compounds associated with diet or medication have an impact on the gut microbiota balance, which in turn, influences the physiologic process. Several reports have shown significant advances in clarifying the impact, interactions and outcomes of oral intake of nanoparticles and the human gut. These interactions may affect the bioavailability of the delivered compounds. In addition, there is a considerable breakthrough in the development of antimicrobial nanoparticles for intestinal pathogenic bacteria. Several in vitro fermentation and in vivo models have been developed throughout the years and were used to test these systems. The methodologies and studies carried out so far on the modulation of human and animal gut microbiome by oral delivery nanosized materials were reviewed. Overall, the available in vitro studies mimic the real physiological events enabling to select the best production conditions of nanoparticulate systems in a preliminary stage of research. On the other hand, animal studies can be used to access the dosage effect, safety and correlation between haematological, biochemical and symptoms, with gut microbiota groups and metabolites.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CBQF-Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Porto, Portugal.
- Amyris Bio Products Portugal, Unipessoal Lda, Porto, Portugal.
ORCID-Profile: Débora Campos, Ana Raquel Madureira
Förderung
- Fundação para a Ciência e a Tecnologia
Zitieren
APA
Campos, D., Goméz-García, R., Oliveira, D., & Madureira, A. R. (2022). Intake of nanoparticles and impact on gut microbiota: in vitro and animal models available for testing. Gut Microbiome, 3. https://doi.org/10.1017/gmb.2021.5
Vancouver
Campos D, Goméz-García R, Oliveira D, Madureira AR. Intake of nanoparticles and impact on gut microbiota: in vitro and animal models available for testing. Gut Microbiome. 2022;3. doi:10.1017/gmb.2021.5
BibTeX
@article{Campos2022,
author = {Campos, Débora and Goméz-García, Ricardo and Oliveira, Diana and Madureira, Ana Raquel},
title = {Intake of nanoparticles and impact on gut microbiota: in vitro and animal models available for testing},
journal = {Gut Microbiome},
year = {2022},
volume = {3},
doi = {10.1017/gmb.2021.5}
}
EUVIMED